Number of the records: 1  

BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide

  1. 1.
    SYSNO ASEP0476521
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleBODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide
    Author(s) Škorpilová, Ludmila (UEB-Q)
    Rimpelová, S. (CZ)
    Jurášek, M. (CZ)
    Buděšínský, Miloš (UOCHB-X) RID, ORCID
    Lokajová, Jana (UOCHB-X)
    Effenberg, R. (CZ)
    Slepička, P. (CZ)
    Ruml, T. (CZ)
    Kmoníčková, Eva (UEM-P) RID
    Drašar, P. B. (CZ)
    Wimmer, Zdeněk (UEB-Q) RID, ORCID
    Number of authors11
    Source TitleBeilstein Journal of Organic Chemistry. - : Beilstein - Institut zur Foerderung der Chemischen Wissenschaften - ISSN 1860-5397
    Roč. 13, JUL 4 (2017), s. 1316-1324
    Number of pages9 s.
    Languageeng - English
    CountryDE - Germany
    KeywordsBODIPY conjugates ; Cancer targeting ; Drug delivery ; Liposomes ; Natural compounds ; Sesquiterpene lactone trilobolide
    Subject RIVCC - Organic Chemistry
    OECD categoryOrganic chemistry
    Subject RIV - cooperationInstitute of Experimental Medicine - Pharmacology ; Medidal Chemistry
    R&D ProjectsLD15012 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LO1304 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUEB-Q - RVO:61389030 ; UOCHB-X - RVO:61388963 ; UEM-P - RVO:68378041
    UT WOS000405427300001
    EID SCOPUS85023616975
    DOI10.3762/bjoc.13.128
    AnnotationLike thapsigargin, which is undergoing clinical trials, trilobolide is a natural product with promising anticancer and anti-inflammatory properties. Similar to thapsigargin, it has limited aqueous solubility that strongly reduces its potential medicinal applications. The targeted delivery of hydrophobic drugs can be achieved using liposome-based carriers. Therefore, we designed a traceable liposomal drug delivery system for trilobolide. The fluorescent green-emitting dye BODIPY, cholesterol and trilobolide were used to create construct 6. The liposomes were composed of dipalmitoyl-3-trimethylammoniumpropane and phosphatidylethanolamine. The whole system was characterized by atomic force microscopy, the average size of the liposomes was 150 nm in width and 30 nm in height. We evaluated the biological activity of construct 6 and its liposomal formulation, both of which showed immunomodulatory properties in primary rat macrophages. The uptake and intracellular distribution of construct 6 and its liposomal formulation was monitored by means of live-cell fluorescence microscopy in two cancer cell lines. The encapsulation of construct 6 into the liposomes improved the drug distribution in cancer cells and was followed by cell death. This new liposomal trilobolide derivative not only retains the biological properties of pure trilobolide, but also enhances the bioavailability, and thus has potential for the use in theranostic applications.
    WorkplaceInstitute of Experimental Botany
    ContactDavid Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.